We are pleased to announce that Prof. Dr. Dawen Zhao has been appointed as Section Editor-in-Chief of “Cancer Causes, Screening and Diagnosis” in Cancers (ISSN: 2072-6694).
Prof. Dr. Dawen Zhao is a Full Professor of biomedical engineering, cancer biology, and translational neuroscience at Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, USA. He has a broad range of interests in the area of cancer research, including cancer imaging, artificial intelligence in imaging, imaging probes, imaging-guided drug delivery, and nanotechnology. His lab has developed several nanoparticle-based imaging probes and therapeutic agents for MRI-guided drug delivery to brain tumors. More recently, his group has published a number of high-impact articles, reporting a novel nano-immunotherapeutic system that effectively mitigates the immune cold tumor microenvironment and enhances anti-cancer immunotherapy against several types of cancer and metastasis. Benefiting from his prior training in clinical medicine and cancer biology, Prof. Dr. Zhao has been actively involved in diverse fields of disease-oriented translational research by integrating genomics and cancer biology with cutting-edge imaging and nanotechnologies. His research is continuously supported by extramural funding. Prof. Dr. Zhao is recognized as an expert in the field, as evidenced by numerous peer-reviewed publications and serving as a standing member of an NIH study section.
The following is a short Q&A with Prof. Dr. Dawen Zhao, who shared his vision for the journal with us, as well as his views on the research area and open access publishing:
1. What aspects of the journal attracted and motivated you to become its Section Editor-in-Chief?
Cancers is committed to advancing rigorous and innovative research. Combined with its global reach within the academic community, Cancers can help shape discourse and guide research priorities. I was motivated by the opportunity to help advance these priorities, support my peers in the research community, and elevate the overall quality of the journal.
2. What is your vision for this Section?
My vision for the Section is to showcase the next generation of cancer diagnostics and treatment. Ultimately, I want this Section to be a leading platform for the research community.
3. What does the future of this field of research look like?
I believe that the future is incredibly bright for cancer research. With the emergence of AI and new diagnostics and treatments, the future will look very different, but it is truly an exciting time to be in research.
4. Do you have any suggestions for young researchers in this field?
Stay curious and persistent! There is no substitute for hard work. Engaging with the research community helps foster a continued interest in science.
5. What do you think of the development of open access in the publishing field?
Open access has democratized the field of research. While challenges remain, I believe that the future of research lies in sustainable, open models.
We warmly welcome Prof. Dr. Dawen Zhao as the Section Editor-in-Chief of “Cancer Causes, Screening and Diagnosis” in Cancers (ISSN: 2072-6694), and we look forward to him leading Cancers to achieve many more milestones.
